purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Phase
1.2.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Phase: 2017 VS 2021 VS 2028
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global Patient Recruitment for Clinical Trials Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Respiratory Diseases
1.3.3 Pain and Anesthesia
1.3.4 Oncology
1.3.5 Central Nervous System
1.3.6 Cardiovascular
1.3.7 Endocrine
1.3.8 Anti-Infective
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient Recruitment for Clinical Trials Market Perspective (2017-2028)
2.2 Patient Recruitment for Clinical Trials Growth Trends by Region
2.2.1 Patient Recruitment for Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Patient Recruitment for Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 Patient Recruitment for Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 Patient Recruitment for Clinical Trials Market Dynamics
2.3.1 Patient Recruitment for Clinical Trials Industry Trends
2.3.2 Patient Recruitment for Clinical Trials Market Drivers
2.3.3 Patient Recruitment for Clinical Trials Market Challenges
2.3.4 Patient Recruitment for Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue
3.1.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global Patient Recruitment for Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global Patient Recruitment for Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patient Recruitment for Clinical Trials Revenue
3.4 Global Patient Recruitment for Clinical Trials Market Concentration Ratio
3.4.1 Global Patient Recruitment for Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Recruitment for Clinical Trials Revenue in 2021
3.5 Patient Recruitment for Clinical Trials Key Players Head office and Area Served
3.6 Key Players Patient Recruitment for Clinical Trials Product Solution and Service
3.7 Date of Enter into Patient Recruitment for Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Recruitment for Clinical Trials Breakdown Data by Phase
4.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Phase (2017-2022)
4.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Phase (2023-2028)
5 Patient Recruitment for Clinical Trials Breakdown Data by Application
5.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Patient Recruitment for Clinical Trials Market Size (2017-2028)
6.2 North America Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
6.3 North America Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Patient Recruitment for Clinical Trials Market Size (2017-2028)
7.2 Europe Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
7.3 Europe Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
8.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Patient Recruitment for Clinical Trials Market Size (2017-2028)
9.2 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
9.3 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
10.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Antidote
11.1.1 Antidote Company Detail
11.1.2 Antidote Business Overview
11.1.3 Antidote Patient Recruitment for Clinical Trials Introduction
11.1.4 Antidote Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.1.5 Antidote Recent Development
11.2 Clara Health
11.2.1 Clara Health Company Detail
11.2.2 Clara Health Business Overview
11.2.3 Clara Health Patient Recruitment for Clinical Trials Introduction
11.2.4 Clara Health Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.2.5 Clara Health Recent Development
11.3 Clariness
11.3.1 Clariness Company Detail
11.3.2 Clariness Business Overview
11.3.3 Clariness Patient Recruitment for Clinical Trials Introduction
11.3.4 Clariness Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.3.5 Clariness Recent Development
11.4 BBK Worldwide
11.4.1 BBK Worldwide Company Detail
11.4.2 BBK Worldwide Business Overview
11.4.3 BBK Worldwide Patient Recruitment for Clinical Trials Introduction
11.4.4 BBK Worldwide Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.4.5 BBK Worldwide Recent Development
11.5 Worldwide Clinical Trials
11.5.1 Worldwide Clinical Trials Company Detail
11.5.2 Worldwide Clinical Trials Business Overview
11.5.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Introduction
11.5.4 Worldwide Clinical Trials Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.5.5 Worldwide Clinical Trials Recent Development
11.6 Clinical Site Services (CCSi)
11.6.1 Clinical Site Services (CCSi) Company Detail
11.6.2 Clinical Site Services (CCSi) Business Overview
11.6.3 Clinical Site Services (CCSi) Patient Recruitment for Clinical Trials Introduction
11.6.4 Clinical Site Services (CCSi) Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.6.5 Clinical Site Services (CCSi) Recent Development
11.7 IQVIA
11.7.1 IQVIA Company Detail
11.7.2 IQVIA Business Overview
11.7.3 IQVIA Patient Recruitment for Clinical Trials Introduction
11.7.4 IQVIA Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.7.5 IQVIA Recent Development
11.8 PPD Inc
11.8.1 PPD Inc Company Detail
11.8.2 PPD Inc Business Overview
11.8.3 PPD Inc Patient Recruitment for Clinical Trials Introduction
11.8.4 PPD Inc Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.8.5 PPD Inc Recent Development
11.9 Veristat
11.9.1 Veristat Company Detail
11.9.2 Veristat Business Overview
11.9.3 Veristat Patient Recruitment for Clinical Trials Introduction
11.9.4 Veristat Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.9.5 Veristat Recent Development
11.10 Elligo Health Research
11.10.1 Elligo Health Research Company Detail
11.10.2 Elligo Health Research Business Overview
11.10.3 Elligo Health Research Patient Recruitment for Clinical Trials Introduction
11.10.4 Elligo Health Research Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.10.5 Elligo Health Research Recent Development
11.11 AutoCruitment
11.11.1 AutoCruitment Company Detail
11.11.2 AutoCruitment Business Overview
11.11.3 AutoCruitment Patient Recruitment for Clinical Trials Introduction
11.11.4 AutoCruitment Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.11.5 AutoCruitment Recent Development
11.12 Clinical Connection
11.12.1 Clinical Connection Company Detail
11.12.2 Clinical Connection Business Overview
11.12.3 Clinical Connection Patient Recruitment for Clinical Trials Introduction
11.12.4 Clinical Connection Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.12.5 Clinical Connection Recent Development
11.13 Biorasi
11.13.1 Biorasi Company Detail
11.13.2 Biorasi Business Overview
11.13.3 Biorasi Patient Recruitment for Clinical Trials Introduction
11.13.4 Biorasi Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.13.5 Biorasi Recent Development
11.14 Curavit Clinical Research
11.14.1 Curavit Clinical Research Company Detail
11.14.2 Curavit Clinical Research Business Overview
11.14.3 Curavit Clinical Research Patient Recruitment for Clinical Trials Introduction
11.14.4 Curavit Clinical Research Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.14.5 Curavit Clinical Research Recent Development
11.15 PatientEvolution
11.15.1 PatientEvolution Company Detail
11.15.2 PatientEvolution Business Overview
11.15.3 PatientEvolution Patient Recruitment for Clinical Trials Introduction
11.15.4 PatientEvolution Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.15.5 PatientEvolution Recent Development
11.16 Praxis
11.16.1 Praxis Company Detail
11.16.2 Praxis Business Overview
11.16.3 Praxis Patient Recruitment for Clinical Trials Introduction
11.16.4 Praxis Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.16.5 Praxis Recent Development
11.17 MMG
11.17.1 MMG Company Detail
11.17.2 MMG Business Overview
11.17.3 MMG Patient Recruitment for Clinical Trials Introduction
11.17.4 MMG Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.17.5 MMG Recent Development
11.18 Science37
11.18.1 Science37 Company Detail
11.18.2 Science37 Business Overview
11.18.3 Science37 Patient Recruitment for Clinical Trials Introduction
11.18.4 Science37 Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.18.5 Science37 Recent Development
11.19 StudyKIK
11.19.1 StudyKIK Company Detail
11.19.2 StudyKIK Business Overview
11.19.3 StudyKIK Patient Recruitment for Clinical Trials Introduction
11.19.4 StudyKIK Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.19.5 StudyKIK Recent Development
11.20 Global AES
11.20.1 Global AES Company Detail
11.20.2 Global AES Business Overview
11.20.3 Global AES Patient Recruitment for Clinical Trials Introduction
11.20.4 Global AES Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.20.5 Global AES Recent Development
11.21 TrialSpark
11.21.1 TrialSpark Company Detail
11.21.2 TrialSpark Business Overview
11.21.3 TrialSpark Patient Recruitment for Clinical Trials Introduction
11.21.4 TrialSpark Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.21.5 TrialSpark Recent Development
11.22 WCG ThreeWire
11.22.1 WCG ThreeWire Company Detail
11.22.2 WCG ThreeWire Business Overview
11.22.3 WCG ThreeWire Patient Recruitment for Clinical Trials Introduction
11.22.4 WCG ThreeWire Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.22.5 WCG ThreeWire Recent Development
11.23 Trialfacts
11.23.1 Trialfacts Company Detail
11.23.2 Trialfacts Business Overview
11.23.3 Trialfacts Patient Recruitment for Clinical Trials Introduction
11.23.4 Trialfacts Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.23.5 Trialfacts Recent Development
11.24 Shanghai Jsure
11.24.1 Shanghai Jsure Company Detail
11.24.2 Shanghai Jsure Business Overview
11.24.3 Shanghai Jsure Patient Recruitment for Clinical Trials Introduction
11.24.4 Shanghai Jsure Revenue in Patient Recruitment for Clinical Trials Business (2017-2022)
11.24.5 Shanghai Jsure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details